The study by Hughes et al.15 showed that Sema6D could affect the activation status of ERK and PI3K/AKT/mTOR signaling pathways and the expression levels of downstream related proteins in humans, thus affecting the proliferation and invasion of tumor cells. This evidence concerns the gene AKT1 and neoplasm.